Related Experiment Videos
Abstract:
N. meningitidis continues to be a worldwide cause of human disease, usually in otherwise healthy individuals. The natural habitat and reservoir for meningococci are the mucosal surfaces of the human nasopharynx and to a lesser extent, the urogenital tract and anal canal. In most instances meningococcal colonization of mucosal surfaces is asymptomatic but may produce local infection. In those individuals who lack serum bactericidal activity against the meningococcus, colonization of mucosal surfaces and bloodstream invasion by N. meningitidis can lead to devastating meningitis and septicemia. Recent studies on the ultrastructure of the meningococcus and on the mechanisms of pathogenesis have given us new insight into meningococcal infections and suggest ways for improved immunoprophylaxis. Currently, penicillin is the drug of choice for the treatment of meningococcal meningitis and septicemia. However, the report of meningococci with antibiotic resistant plasmids is alarming and in the future may alter traditional treatment regimens.
Insights
Neisseria meningitidis (N. meningitidis) causes widespread human disease, often leading to meningitis and septicemia in susceptible individuals. Emerging antibiotic resistance in N. meningitidis poses a significant threat to current treatment strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Immunology
Background:
- Neisseria meningitidis (N. meningitidis) is a significant global pathogen, primarily colonizing the human nasopharynx.
- Colonization is often asymptomatic but can lead to invasive diseases like meningitis and septicemia, particularly in individuals lacking bactericidal antibodies.
- Understanding N. meningitidis pathogenesis is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To review current understanding of N. meningitidis infections.
- To highlight recent advances in understanding meningococcal ultrastructure and pathogenesis.
- To discuss implications for immunoprophylaxis and current treatment regimens.
Main Methods:
- Literature review of N. meningitidis ultrastructure and pathogenesis.
- Analysis of clinical data regarding meningococcal disease.
- Assessment of current treatment protocols and emerging resistance patterns.
Main Results:
- N. meningitidis resides in the human nasopharynx, with asymptomatic colonization being common.
- Invasive disease occurs in individuals with deficient serum bactericidal activity.
- Recent research provides insights into meningococcal pathogenesis and potential for improved immunoprophylaxis.
Conclusions:
- N. meningitidis remains a critical cause of bacterial meningitis and septicemia worldwide.
- Emerging antibiotic resistance in N. meningitidis necessitates ongoing surveillance and may impact future treatment.
- Further research into meningococcal pathogenesis and host immunity is vital for enhanced disease control.